Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cellapeutics bio logo — Global standard of cell reprogramming platform

Cellapeutics bio

Global standard of cell reprogramming platform

Founded 2020 Korea South Korea South 8 employees Seed Biotechnology, Pharmaceutical

General Information

Company Name Cellapeutics bio
Founded Year 2020
Location Korea South Korea South +1
Employees 8
Industries Biotechnology, Pharmaceutical
Funding Stage Seed
Social

Get notified when Cellapeutics bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cellapeutics bio

Cellapeutics Bio, with the slogan "Global standard of cell reprogramming platform," is a bio-venture company founded in 2020. The company operates in the Biotechnology and Pharmaceutical industries, with its headquarters located in Korea South. Cellapeutics Bio specializes in developing cell therapy for the treatment of degenerative and intractable nerve damage using somatic cell reprogramming platform technology. The company recently secured a Seed Round investment on 01 October 2021, with the investment coming from Apimeds.

Taxonomy: Cell Biology, Neuroscience, Drug Development, Cell Therapy, Somatic Cell Reprogramming, Regenerative Medicine

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1 •••• •••• 01 Oct 2021
Seed Round •••••• 3
Investor Investor Investor
21 Jun 2021
Pre Seed Round •••••• 2
Investor
•••• •••• 		01 Jun 2020

Cellapeutics bio Alternatives & Competitors

Cellapeutics bio vs
Appia Bio
Appia Bio

Collaborates across a diversity of disciplines, which is critical to developing next-generation ther...

Series A
13 employees
Biotechnology, Health Care
Cellapeutics bio vs
Generation Bio
Generation Bio United States

We're changing what's possible for people living with T cell-driven autoimmune disease.

36 employees
Cellapeutics bio vs
Inceptor Bio
Inceptor Bio United States

Advancing Cell and Gene Therapies to Cure Cancer

Debt Financing
28 employees
Biotechnology, Health Care

FAQ About Cellapeutics bio

Global standard of cell reprogramming platform
Cellapeutics bio was founded in 2020.
Cellapeutics bio is headquartered in Korea South.
Cellapeutics bio operates in the following industries: Biotechnology, Pharmaceutical.
Cellapeutics bio has approximately 8 employees.
Cellapeutics bio has completed 3 funding rounds. The latest funding stage is Seed.
Top alternatives and competitors to Cellapeutics bio include Appia Bio, Generation Bio, Inceptor Bio, Be Biopharma, BioInno. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellapeutics bio and Appia Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cellapeutics bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy